TWA
IPXL

TCI Wealth Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

TCI Wealth Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-59
Closed -$1K – 1687
2018
Q1 		$1K Hold
59
– – ﹤0.01% 1329
2017
Q4 		$1K Buy
59
+23
+64% +$422 ﹤0.01% 1350
2017
Q3 		$1K Buy
+36
New +$688 ﹤0.01% 1291

TCI Wealth Advisors's IPXL Position: Q2 2018 in Review

TCI Wealth Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 59 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in IPXL in Q3 2017 and held it in 3 quarters. The position peaked at $1K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • TCI Wealth Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • TCI Wealth Advisors sold 59 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1K.
  • TCI Wealth Advisors first reported a position in Impax Laboratories, Inc. in Q3 2017 and held it in 3 quarters.
  • TCI Wealth Advisors's Impax Laboratories, Inc. position peaked at $1K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on TCI Wealth Advisors's 13F filing for Q2 2018, filed 27 Jul 2018.